Pilot study of a new tool to optimise dopaminergic treatment in Parkinson's disease: the OPTIMIPARK questionnaire

CONCLUSIONS: Although still pending a validation study, OPTIMIPARK may be a viable and useful questionnaire for clinical decision-making in the therapeutic adjustment of PD patients and the identification of candidates for advanced therapies.PMID:33710607 | DOI:10.33588/rn.7206.2020259

Source: Revista de Neurologia - March 12, 2021 Category: Neurology Authors: J U M áñez-Miró F Vivancos-Matellano J Wetmore P Mart ínez-Martín Source Type: research